Mammalian target of rapamycin complex 1 and FoxO1 in the transcriptional control of lipolysis and de novo lipogenesis

被引：3
|
作者：
Kandror, Konstantin V. [1 ]
机构：
[1] Boston Univ, Sch Med, Dept Biochem, K123D,715 Albany St, Boston, MA 02118 USA
来源：
CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY | 2017年 / 24卷 / 05期
关键词：
adipose triglyceride lipase; early growth response 1; FoxO1; lipogenesis; lipolysis; mammalian target of rapamycin complex 1; ADIPOSE TRIGLYCERIDE LIPASE; HEPATIC LIPID-METABOLISM; FAT-SPECIFIC PROTEIN-27; DIET-INDUCED OBESITY; ADIPOCYTE DIFFERENTIATION; INSULIN-RESISTANCE; SIGNALING PATHWAY; GENE-EXPRESSION; TRIACYLGLYCEROL LIPASE; INHIBITS LIPOLYSIS;
D O I：
10.1097/MED.0000000000000352
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Purpose of reviewPostprandial suppression of lipolysis in adipose tissue and stimulation of de novo lipogenesis (DNL) in the liver by insulin are essential for the metabolic homeostasis in the mammalian organism. The mechanism of coregulation of lipolysis and DNL is not clear.Recent findingsInsulin controls both lipolysis and DNL at the level of transcription via the same mammalian target of rapamycin complex 1 (mTORC1) and FoxO1-mediated signaling pathways.SummarymTORC1 suppresses lipolysis in adipose tissue and activates DNL in the liver, whereas FoxO1 has the opposite effect. Individual inputs of either mTORC1 or FoxO1 in the regulation of lipid metabolism may be difficult to evaluate because of the cross talk between these pathways.
引用
收藏
页码：326 / 331
页数：6
相关论文
共 50 条
  • [21] Mammalian target of rapamycin complex 1 (mTORC1) signaling in energy balance and obesity
    Cota, Daniela
    PHYSIOLOGY & BEHAVIOR, 2009, 97 (05) : 520 - 524
  • [22] Mammalian target of rapamycin complex 1 as an inducer of neurotrophic factors in dopaminergic neurons
    Kim, Sang Ryong
    NEURAL REGENERATION RESEARCH, 2014, 9 (23) : 2036 - 2037
  • [23] FOXO1 Signaling in the Control of Bone Mass
    Rached, M.
    Ogita, M.
    DePinho, R. A.
    Bilezikian, J. P.
    Kousteni, S.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2008, 23 : S32 - S32
  • [24] Regulation of mammalian target of rapamycin complex 1 (mTORC1) by hypoxia: causes and consequences
    Hakan Cam
    Peter J. Houghton
    Targeted Oncology, 2011, 6 : 95 - 102
  • [25] Regulation of mammalian target of rapamycin complex 1 (mTORC1) by hypoxia: causes and consequences
    Cam, Hakan
    Houghton, Peter J.
    TARGETED ONCOLOGY, 2011, 6 (02) : 95 - 102
  • [26] Mammalian target of rapamycin complex 1 as an inducer of neurotrophic factors in dopaminergic neurons
    Sang Ryong Kim
    NeuralRegenerationResearch, 2014, 9 (23) : 2036 - 2037
  • [27] Mammalian target of rapamycin complex 1 signalling is essential for germinal centre reaction
    Li, Bingshou
    Li, Zhirong
    Wang, Pengcheng
    Huang, Qizhao
    Xu, Lifan
    He, Ran
    Ye, Lilin
    Bai, Qiang
    IMMUNOLOGY, 2017, 152 (02) : 276 - 286
  • [28] Mammalian target of rapamycin complex 1: Signalling inputs, substrates and feedback mechanisms
    Dunlop, E. A.
    Tee, A. R.
    CELLULAR SIGNALLING, 2009, 21 (06) : 827 - 835
  • [29] MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1 IS INVOLVED IN DIFFERENTIATION OF REGENERATING MYOFIBERS IN VIVO
    Miyabara, Elen H.
    Conte, Talita C.
    Silva, Meiricris T.
    Baptista, Igor L.
    Bueno, Carlos, Jr.
    Fiamoncini, Jarlei
    Lambertucci, Rafael H.
    Serra, Carmen S.
    Brum, Patricia C.
    Pithon-curi, Tania
    Curi, Rui
    Aoki, Marcelo S.
    Oliveira, Antonio C.
    Moriscot, Anselmo S.
    MUSCLE & NERVE, 2010, 42 (05) : 778 - 787
  • [30] Conversion to mammalian target of rapamycin inhibitors in kidney transplant recipients with de novo cancers
    Cheung, Chi Yuen
    Ma, Maggie Kam Man
    Chak, Wai Leung
    Chau, Ka Foon
    Tang, Sydney Chi Wai
    ONCOTARGET, 2017, 8 (27) : 44833 - 44841
12345